Company Name: The ACME Laboratories Limited
Print Company Information
Untitled Document
Trading Code: ACMELAB Scrip Code: 18491
Untitled Document
Figure in BDT    
Market Information: Nov 20, 2017

Last Trading Price 113.70
Last Update 4:00 PM
Change*
-0.6
-0.52%
Opening Price 114.40
Adjusted Opening Price 114.30
Yesterday's Closing Price 114.30
Closing Price 113.60
Day's Range 112.70 - 114.50
Day's Value (mn) 17.541
52 Weeks' Moving Range 97.30 - 122.40
Day's Volume (Nos.) 154,158
Day's Trade (Nos.) 294
Market Capitalization (mn) 24,186.074
*Based on Yesterday's Closing Price and Last Trading Price.

Basic Information

Authorized Capital (mn) 5,000.00
Paid-up Capital (mn) 2,116.02
Face/par Value 10.0
Total No. of Outstanding Securities 211,601,700
Debut Trading Date 07 Jun, 2016
Type of Instrument Equity
Market Lot 1
Sector Pharmaceuticals & Chemicals
Untitled Document
Closing Price Graph:     Total Trade Graph:     Total Volume Graph:    

Last AGM held on: 07/11/2016
For the year ended: Jun 30, 2016

Cash Dividend 35% 2016
Bonus Issue (Stock Dividend) -
Right Issue -
Year End 30-Jun
Reserve & Surplus without OCI (mn) 9,120.4
Other Comprehensive Income (OCI) (mn) 0.4

 

Interim Financial Performance: 2017

Particulars Unaudited / Audited
Q1 Q2 Half Yearly Q3 9 Months
Annual
Ending on Ending on 6 Months
Ending on Ending on
201709
Turnover/Revenue (mn) 3572.51 - - - - -
Profit from continuing operations (mn) 421.11 - - - - -
Profit for the period (mn) 421.11 - - - - -
Total Comprehensive Income for the period (mn) 421.11 - - - - -
Earnings Per Share (EPS)
Basic 1.990 - - - - -
Diluted* - - - - - -
Earnings Per Share (EPS) - continuing operations
Basic 1.990 - - - - -
Diluted* - - - - - -
Market price per share at period end 113.2 - - - - -
*As per BSEC Directive No. SEC/CMRRCD/2009-193/64, dated September 21, 2010.

Price Earnings (P/E) Ratio based on latest Un-audited Financial Statements

Particulars Nov 13, 2017Nov 14, 2017Nov 15, 2017Nov 16, 2017Nov 19, 2017Nov 20, 2017
Current P/E Ratio using Basic EPS
(Continuing core operations)**
14.0714.4614.4514.4314.3614.27
Current P/E ratio using Diluted EPS***
(Continuing core operation)
------

 

Price Earnings (P/E) Ratio Based on latest Audited Financial Statements

Particulars Nov 13, 2017Nov 14, 2017Nov 15, 2017Nov 16, 2017Nov 19, 2017Nov 20, 2017
Current P/E Ratio using Basic EPS
(Continuing core operations)**
17.117.5717.5617.5417.4517.34
Current P/E ratio using Diluted EPS***
(Continuing core operation)
------
** Usually refers to "Continuing operations".
*** Calculated using bonus-adjusted number of shares as per BSEC Directive (not as per IAS 33 or BAS 33).

Financial Performance as per Audited Financial Statements as per IFRS/IAS or BFRS/BAS

Year Earnings per share(EPS) EPS - Continuing Operations NAV Per Share Profit/(Loss) and OCI
Basic Diluted
Basic Diluted
PCO* Profit for the year (mn) TCI*
Original Restated Original Restated Original Restated Diluted
2013 - - - 4.19 - - 61.15 - - 505.70 505.70 505.70
2014 - - - 5.65 - - 66.16 - - 893.89 893.89 894.73
2015 - - - 5.70 - 4.36 70.37 - 73.10 921.92 921.92 922.90
2016 - - - 6.55 - - 77.34 - - 1101.27 1101.27 1101.27
PCO = Profit from Continuing Operations (mn)
TCI = Total Comprehensive Income for the year (mn)

Financial Performance... (Continued)

Year Year end Price Earnings (P/E) ratio Dividend in %* Dividend Yield in %
Earnings per share(EPS) EPS - Continuing Operations
Using Basic EPS Using
Diluted EPS
Using Basic EPS Using
Diluted EPS
Original Restated
Original Restated
2013 - - - - - - - -
2014 - - - - - - - -
2015 - - - - - - - -
2016 - - - 17.77 - - 35.00 3.01
*B for bonus or stock dividend, otherwise cash.
*Note: Price Earnings (P/E) Ratio has been calculated as per annual financial statements submitted by the listed securities by adopting uniform income year from July to June in compliance with the provisions of the Finance Act, 2015 and BSEC Directive No. SEC/SRMIC/2011/1240/445 dated April 27, 2016. For the first time adoption of the change in the financial year, listed companies, those year-ended on March, April, July, August, September, October and December, submitted their audited accounts by adding next few months or reducing few months and P/E has been calculated accordingly.
Details of Financial Statement
Price Sensitive Information

 

Other Information of the Company

Listing Year 2016
Market Category A
Electronic Share Y
Share Holding Percentage [as on Jun 30, 2016 (year ended)]
Sponsor/Director:
38.88
Govt:
0.00
Institute:
26.54
Foreign:
0.48
Public:
34.10
Share Holding Percentage [as on Sep 30, 2017]
Sponsor/Director:
39.95
Govt:
0.00
Institute:
26.90
Foreign:
3.45
Public:
29.70
Share Holding Percentage [as on Oct 31, 2017]
Sponsor/Director:
40.01
Govt:
0.00
Institute:
27.17
Foreign:
3.57
Public:
29.25
Remarks 1. Data are provided as per company prospectus. 2. The NAV & EPS of last Financial Statements have been calculated considering Post-IPO Number of Shares. 3. TK 5,642,930,494 Revaluation Reserve has been added to Reserve & Surplus.
Note: This is information for the concerned that total holdings of Sponsors/Directors of most of the listed securities have changed from the month of June, 2016 than that of earlier reporting mainly due to compliance of the regulation 2(r) of the Dhaka Stock Exchange (Listing) Regulations, 2015 which reads QUOTE Sponsor means any person or institution who subscribes to the initial capital of a company or a mutual fund or a collective investment scheme. UNQUOTE
Corporate Performance at a glance

Present Operational Status Active
Present Loan Status as on June 30, 2016
  Short-term loan (mn) 4709.65
Long-term loan (mn) 3637.65
Latest Dividend Status (%) 35.00 for 2016
Latest Credit Rating Status
  Short-term
Long-term
OTC/Delisting/Relisting

 

Address of the Company

Address The ACME Laboratories Limited
ACME Group
Court de la ACME
1/4, Mirpur Road, Kallayanpur,
Dhaka - 1207, Bangladesh.
Contact Phone +88 02 9004194-6
Fax +88 02 9016872
E-mail headoffice@acmeglobal.com
Web Address http://acmeglobal.com

Note: All dynamic information of this page are only valid for Public and Debt board.
Disclaimer: This page is now under updating process. If any anomalies are found , please inform us (phone: 88-02-9564601, 7175703-11, Ext- 259).

 




STOCK EXCHANGE BUILDING, 9/F MOTIJHEEL C/A, DHAKA BANGLADESH
Phone: 88-02-9564601, 7175703-11, FAX: +88-02-9564727
Email: dse@bol-online.com, Web: http://www.dsebd.org/